Unveiling Enzene’s State-of-the-Art Manufacturing Facility in New Jersey, United States

Step into the future of biologics manufacturing at Enzene’s newly unveiled facility in New Jersey—the first site in the U.S. featuring Fully Connected Continuous Manufacturing™ (FCCM™) technology. This cutting-edge facility is revolutionizing biologics production, offering unmatched efficiency, scalability, and quality. Discover how we’re transforming the industry and accelerating access to life-saving therapies.